Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
54.01
+0.62 (1.16%)
At close: Jul 22, 2026, 4:00 PM EDT
53.81
-0.20 (-0.37%)
Pre-market: Jul 23, 2026, 8:15 AM EDT
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Ionis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $92.95. The average 1-year stock price forecast is 72.10% higher than the current stock price, while the lowest is $68 (+25.90%) and the highest is $125 (+131.44%).
Price Target: $92.95 (+72.10%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ionis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 11 | 12 | 12 | 10 |
| Buy | 6 | 6 | 8 | 9 | 8 | 9 |
| Hold | 6 | 6 | 5 | 5 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 24 | 26 | 24 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $100 | Buy | Maintains | $100 | +85.15% | Jul 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $125 | Buy | Reiterates | $125 | +131.44% | Jul 23, 2026 |
| Barclays | Barclays | Buy Maintains $90 | Buy | Maintains | $90 | +66.64% | Jul 23, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $95 | Buy | Maintains | $95 | +75.89% | Jul 23, 2026 |
| Needham | Needham | Buy Maintains $86 | Buy | Maintains | $86 | +59.23% | Jul 22, 2026 |
Financial Forecast
Revenue This Year
889.18M
from 943.71M
Decreased by -5.78%
Revenue Next Year
1.39B
from 889.18M
Increased by 56.16%
EPS This Year
-2.61
from -1.54
EPS Next Year
-1.14
from -2.61
EPS and Forward PE are based on non-GAAP adjusted numbers.